Patents by Inventor Marie Classon

Marie Classon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20170209444
    Abstract: Provided herein are methods of using antagonists of G9a, for example, for treating cancer and/or preventing drug resistance in an individual. For example, a method of treating cancer in an individual comprising administering to the individual an antagonist of G9a alone or in combination with a cancer therapy agent is provided. In some embodiments, the antagonist of G9a increases the period of cancer sensitivity and/or delays development of cancer resistance.
    Type: Application
    Filed: June 23, 2015
    Publication date: July 27, 2017
    Applicant: Genentech Inc.
    Inventors: Marie Classon, Gulfem Dilek Guler, Robert Pitti, Jean-Philippe Stephan, Charles Albert Tindell
  • Publication number: 20160160213
    Abstract: Provided herein are methods of treating and/or preventing cancer drug resistance using modulators of chromatin modifiers (e.g., antagonists of chromatin modifiers) described herein.
    Type: Application
    Filed: September 14, 2015
    Publication date: June 9, 2016
    Applicant: GENENTECH, INC.
    Inventors: Marie Classon, Jean-Philippe Stephan
  • Publication number: 20160143910
    Abstract: Provided herein are methods of treating and/or preventing cancer drug resistance using antagonists of KDM5.
    Type: Application
    Filed: March 14, 2014
    Publication date: May 26, 2016
    Applicants: CONSTELLATION PHARMACEUTICALS, INC., GENENTECH, INC.
    Inventors: Shilpi Arora, Michael Robert Costa, Ted Lau, Patrick Trojer, Brian K. Albrecht, Shane Buker, Marie Classon, Victor S. Gehling, Jean-Christophe Harmange, Erica L. Jackson, Jun Liang, Heidi Phillips, Peter Sandy, Jeffrey Settleman, Jean-Philippe Stephan